Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BOLT
BOLT BIOTHERAPEUTICS, INC.
NASDAQ
$3.81
▼ DOWN 4.62% (-0.18)

KEY STATISTICS

Market Cap$7.33 M
52w High$7.20
52w Low$3.13
Dividend Yield0.06%
FrequencyQuarterly
P/E-0.23
Volume24.96K
Shares Out.1.92M

COMPANY

LEADERSHIP

William Quinn
CHIEF EXECUTIVE
William Quinn

COMPENSATION 2026

Salary$463,500
Stock Awards$224,400
Incentive Plan Pay$0
All Other Comp.$10,500
Total$4,558,368

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 5, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
23

PRICE TARGET

Target High$7.00
Target Low$1.00
Target Median$4.00
Target Consensus$4.00

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$426.25K
NOV
11
WED

SPLIT RECORD

DATETYPERATIO
2025-06-09Reverse1:20

PRICE

$3.81 ▼ DOWN 4.62% (−$0.18)
OVERLAYS
$3.90$4.05$4.209:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM3.81

About Bolt Biotherapeutics, Inc.

https://www.boltbio.com ↗

Bolt Biotherapeutics, a California-based biotech company, develops immuno-oncology agents like BDC-1001 and BDC-2034 targeting tumor cells and the tumor microenvironment, currently in clinical trials for various solid tumors.

INDUSTRY

Biotechnology

A PRODUCT BOLT BIOTHERAPEUTICS, INC. IS KNOWN FOR

BDC-4182
BDC-4182

BDC-4182 is a Boltbody™ ISAC targeting claudin 18.2 in cancers like gastric and pancreatic, currently in Phase 1 trials as the company's leading targeted immunotherapy candidate.

COMPETITORS

COMPETITOR
AMGN COMPARE
JANX COMPARE
NBP COMPARE
XNCR COMPARE
ZLAB COMPARE

Revenue by Products

IconPRODUCTQ4-2013Q1-2014Q2-2014Q3-2014
Consolidated— — — $11.91M
Underwater Robotic Vehicles$8.03M $6.41M ▼$3.89M ▼$5.47M ▲
Seismic Energy Sources$7.88M $4.79M ▼$5.32M ▲$3.67M ▼
Underwater Cables and Connectors$4.45M $3.76M ▼$3.96M ▲$2.46M ▼
Seismic Energy Source Controllers$1.38M $755K ▼$682K ▼$313K ▼
Corporate Headquarters and Eliminations$0 $0 $0 $0

Revenue by Geography

MapREGIONQ2-2013Q2-2014
Foreign countries$35.68M $42.38M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 7.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
83.18%
HOLDERS
35
TOP 12 OF 35 · RANKED BY POSITION SIZE
Hawkeye Capital Management, LLC
415.0K sh · $431.64K
Blackrock Inc.
267.1K sh · $200.3K
Pictet Asset Management Ltd
186.4K sh · $2.88M
Vivo Capital, LLC
176.1K sh · $936.66K
Sofinnova Investments, Inc.
137.7K sh · $556.39K
Pivotal Bioventure Partners Investment Advisor LLC
94.6K sh · $517.13K
Renaissance Technologies LLC
77.2K sh · $311.99K
Tang Capital Management LLC
66.9K sh · $355.8K
Nan Fung Group Holdings Ltd
58.3K sh · $319.04K
Samsara Biocapital, LLC
48.8K sh · $259.78K
Board Of Trustees Of The Leland Stanford Junior University
36.0K sh · $191.4K
Vanguard Group Inc
34.2K sh · $182.11K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

★
DIRECTOR
Dupont Jakob
Purchase · 5.0K shares
2026-06-10
★
DIRECTOR
Berner Laura
Purchase · 5.0K shares
2026-06-10
★
DIRECTOR
O'CALLAGHAN BRIAN
Purchase · 5.0K shares
2026-06-10
★
DIRECTOR
ONETTO NICOLE
Purchase · 5.0K shares
2026-06-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
CING$5.33COMPARE
MRKR$1.37COMPARE
CLRB$2.53COMPARE
AEON$0.31COMPARE
INAB$1.03COMPARE
IMNN$1.60COMPARE
EVGN$0.55COMPARE
RNAZ$2.18COMPARE